Belgian Biotech’s Leukemia CAR-T Treatment Leaves Patient Cancer-Free – Labiotech.eu (blog)
Labiotech.eu (blog) |
Belgian Biotech's Leukemia CAR–T Treatment Leaves Patient Cancer-Free
Labiotech.eu (blog) Celyad has announced early results from a clinical trial, where a patient has been cleared of cancer after treatment with its alternative CAR–T cell therapy. Celyad has pioneered a unique Natural Killer Receptor (NKR) T cell platform for the treatment … |
